Maryam Oskoui
Investigator
Pediatric Neurologist, Neurophysiologist and Epidemiologist, Montreal Children’s Hospital
Professor, Departments of Pediatrics and Neurology and Neurosurgery, McGill University | Scientist, Research Institute of the McGill University Health Centre
NMD4C Involvement: Pillar 2: Clinical Research
Email MaryamBiography
Dr. Maryam Oskoui is a pediatric neurologist, neurophysiologist and epidemiologist. She is a Distinguished Clinical Research Scholar of the Fonds de Recherche Quebec with a focus in clinical research and clinical trials in pediatric neuromuscular disorders and has contributed to over 100 peer reviewed publications. She is a Principal investigator and SMA lead for INFORM RARE, a Strategy for Patient Oriented Research innovative clinical trial initiative supported by CIHR.
Dr. Oskoui serves as an evidence-based methodologist for the American Academy of Neurology and has contributed to numerous clinical care guidelines. She contributes to the Canadian Neuromuscular community by serving as a member of the Scientific Advisory Committee for Muscular Dystrophy Canada and is past chair of the Canadian Pediatric Neuromuscular Group and the Canadian Neuromuscular Disease Registry’s Spinal Muscular Atrophy Working Group. She is a Board member for the Association des Neurologues du Quebec
Dr. Oskoui completed her medical school and pediatric neurology residency at McGill University (Montreal, Canada), neuromuscular clinical and research fellowship at Columbia University (New York, USA) and Master’s of Science in Clinical Epidemiology at McGill University.
Recent Publications
Tolchin, B, Goldstein, LH, Reuber, M, Stone, J, Perez, DL, LaFrance, WC Jr et al.. Management of Functional Seizures Practice Guideline Executive Summary: Report of the AAN Guidelines Subcommittee. Neurology. 2026.106 (1)e214466 PMID:41370742
Kwon, JM, Munell, F, Le Goff, L, Yuge, K, Kato, T, Cances, C et al.. Intrathecal onasemnogene abeparvovec for treatment-experienced patients with spinal muscular atrophy: a phase 3b, open-label trial. Nat Med. 2025. PMID:41360995
Groulx-Boivin, E, Belzile, A, Nguyen, CÉ, Gauthier, A, Chrestian, N, Michaud-Gosselin, C et al.. Quebec Spinal Muscular Atrophy Newborn Screening Program: The First Year Experience. Int J Neonatal Screen. 2025.11 (4) PMID:41133701
Junges, C, Garfinkle, J, Oskoui, M. Nasotracheal Intubation in Extreme Prematurity and Traumatic Brain Injury: A Cautionary Tale. Case Rep Pediatr. 2025.2025 3005450 PMID:41079043
Iraqi, I, Ng, P, Chen, X, Cushen, N, Gottowik, J, Herzig, D et al.. Feasibility of a Home-Based Exergaming Intervention for Youth With Spinal Muscular Atrophy. Muscle Nerve. 2025.72 (6)1259-1264 PMID:40990108
See more on PubMed